Discover 1,083 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
With many research studies being conducted across the state, Indiana provides opportunities for both healthy volunteers interested in paid studies and individuals with specific health needs. Research centers in Indianapolis, Fort Wayne, and South Bend are actively recruiting participants, granting access to advanced treatments and innovative healthcare.
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
Active & Responsive
Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring
for
Dysphagia, Esophageal
Location: 1 recruiting location
Sponsor: Indiana University
Sex: All
Age: 18 - 70+
Code: NCT04503785
Recruiting
Active & Responsive
Alzheimer's Disease Genetics Study
for
Alzheimer Disease, Late Onset Alzheimer Disease, Dementia
Location: 1 recruiting location
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT00064870
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: 19 recruiting locations
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase1, Recruiting
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: 41 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions